Literature DB >> 27995339

Cardiovascular complications of type 1 diabetes: update on the renal link.

Trevor J Orchard1, Tina Costacou2.   

Abstract

AIMS: Despite recent findings of increased life expectancy among individuals with type 1 diabetes, mortality remains greatly increased compared to the general population. As this is largely the result of cardiovascular and renal complications, we aimed to review recent findings surrounding these diseases in type 1 diabetes.
METHODS: We reviewed published findings concerning the cardiovascular complications of type 1 diabetes, with a particular focus on links with renal disease.
RESULTS: The cardiovascular and renal complications of type 1 diabetes share many features including insulin resistance, oxidative damage, and genetic associations with the Haptoglobin genotype, and both are strongly affected by glycemic control.
CONCLUSIONS: Although current knowledge on predictors of type 1 diabetes cardiovascular and renal complications has increased, further investigation is required to understand the mechanisms leading to cardio-renal complications in this population.

Entities:  

Keywords:  Haptoglobin genotype; Type 1 diabetes; cardio-renal link; cardiovascular disease; kidney disease

Mesh:

Substances:

Year:  2016        PMID: 27995339     DOI: 10.1007/s00592-016-0949-7

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  7 in total

1.  Risk Factor Modeling for Cardiovascular Disease in Type 1 Diabetes in the Pittsburgh Epidemiology of Diabetes Complications (EDC) Study: A Comparison With the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC).

Authors:  Rachel G Miller; Tina Costacou; Trevor J Orchard
Journal:  Diabetes       Date:  2018-11-08       Impact factor: 9.461

2.  Elevated copeptin, arterial stiffness, and elevated albumin excretion in adolescents with type 1 diabetes.

Authors:  Pattara Wiromrat; Petter Bjornstad; Carissa Vinovskis; Linh T Chung; Carlos Roncal; Laura Pyle; Miguel A Lanaspa; Richard J Johnson; David Z Cherney; Tyler K Reznick-Lipina; Franziska Bishop; David M Maahs; Raj Paul Wadwa
Journal:  Pediatr Diabetes       Date:  2019-08-29       Impact factor: 4.866

3.  Cardioprotective role of GTS-21 by attenuating the TLR4/NF-κB pathway in streptozotocin-induced diabetic cardiomyopathy in rats.

Authors:  Mahmoud E Youssef; Heba M Abdelrazek; Yasser M Moustafa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-08-10       Impact factor: 3.000

4.  Risk of retinal artery occlusion in patients with diabetes mellitus: A retrospective large-scale cohort study.

Authors:  Yuh-Shin Chang; Chung-Han Ho; Chin-Chen Chu; Jhi-Joung Wang; Sung-Huei Tseng; Ren-Long Jan
Journal:  PLoS One       Date:  2018-08-09       Impact factor: 3.240

5.  In vivo and in vitro studies of Danzhi Jiangtang capsules against diabetic cardiomyopathy via TLR4/MyD88/NF-κB signaling pathway.

Authors:  Hui Shi; Peng Zhou; Ying-Qun Ni; Shu-Shu Wang; Rui Song; An-Lu Shen; Zhao-Hui Fang; Liang Wang
Journal:  Saudi Pharm J       Date:  2021-11-09       Impact factor: 4.330

6.  Risk Factors for Cardiovascular Disease (CVD) in Adults with Type 1 Diabetes: Findings from Prospective Real-life T1D Exchange Registry.

Authors:  Viral N Shah; Ryan Bailey; Mengdi Wu; Nicole C Foster; Rodica Pop-Busui; Michelle Katz; Jill Crandall; Fida Bacha; Kristen Nadeau; Ingrid Libman; Paul Hiers; Kara Mizokami-Stout; Linda A DiMeglio; Jennifer Sherr; Richard Pratley; Shivani Agarwal; Janet Snell-Bergeon; Eda Cengiz; Sarit Polsky; Sanjeev N Mehta
Journal:  J Clin Endocrinol Metab       Date:  2020-05-01       Impact factor: 5.958

7.  Thrombopoietin Contributes to Enhanced Platelet Activation in Patients with Type 1 Diabetes Mellitus.

Authors:  Ornella Bosco; Barbara Vizio; Gabriella Gruden; Martina Schiavello; Bartolomeo Lorenzati; Paolo Cavallo-Perin; Isabella Russo; Giuseppe Montrucchio; Enrico Lupia
Journal:  Int J Mol Sci       Date:  2021-06-29       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.